CLOs on the Move

Rubenstein Partners

www.rubensteinpartners.com

 
Rubenstein Partners is the fund manager for a series of private equity funds focused on office investments throughout the United States. The firm is vertically-integrated and provides first-class investment services on behalf of its investor base, which consists of some of the nation`s preeminent public and private pension funds, university endowments, foundations and family offices. The firm, including its predecessor company, has nearly a 50-year history as a vertically-integrated owner and operator, with the office asset class serving as our exclusive investment focus over the last 20 years. This narrow investment mandate affords us the luxury of dedicating our energy, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
David Walker
Associate General Counsel Profile

Similar Companies

enGene

At enGene, we are at the vanguard of a new era in genetic medicine: Our novel Dually Derivatized Oligochitosan® (DDX) gene delivery platform is designed to enable localized delivery of multiple gene cargos, including RNA and DNA, directly to mucosal tissues and other organs — potentially overcoming the limitations of viral-based gene therapies and advancing gene therapy beyond rare genetic diseases into the mainstream of clinical practice. Our breakthrough Dually Derivatized Oligochitosan® (DDX) platform opens possibilities for streamlining the use of genetic medicines in the treatment of serious diseases, especially diseases afflicting mucosal tissues. Our lead product candidate, EG-70 (detalimogene voraplasmid), is a non-viral immunotherapy in development to treat non-muscle invasive bladder cancer (NMIBC), a disease with a significant patient burden, high clinical needs, and massive healthcare system economic impact. Based on its preliminary efficacy and safety profile and ease of administration by urologists, EG-70, which is currently in a pivotal trial, can potentially benefit patients across a wide variety of clinical settings. As enGeneers, we are boldly focused on patients needs. We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, respiratory, and several other therapeutic areas. Nasdaq: ENGN

WoodWare Systems

WoodWare Systems is a Memphis, TN-based company in the Business Services sector.

Ignite

The owner of this domain has not yet uploaded their website.

Dipix Technologies

Dipix Technologies Inc. is a Ottawa, ON-based company in the Business Services sector.

Modern Process Control

Modern Process Control is a Sidney, BC-based company in the Business Services sector.